InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results
04 nov. 2024 16h30 HE | Interpace Biosciences, Inc.
 ●Q3 Revenue of $12.3 million; a $3.2M and 35% increase year-over-year ●Q3 Test volume up 26% year over year to record levels ●Q3 Cash collections of $11.3M; a $1.4M and 15% increase...